Laminin 521

Laminin 521 Liste de produits

Attribut
Protein (7)Kits (1)Panel (1)
Bibliothèque de produits
En ligne (9)
Espèces
Human (9)
Étiquette
- (9)
Marqueur
Unconjugated (7)- (2)

Numéro de produit	Espèces	Système d'expression	Description du produit	Pré-commande/Commande
HOT GMP-LA5H24	Human	HEK293	GMP Human Laminin 521 Protein	Ajouter au panier
HOT GMP-LA5H24GA02	Human	HEK293	GMP Human Laminin 521 Protein (Liquid)	Ajouter au panier
HOT LA5-H5213L	Human	HEK293	Human Laminin 521 Protein, premium grade (Liquid)	Ajouter au panier
HOT LA5-H5261	Human	HEK293	Human Laminin 521 Protein, premium grade	Ajouter au panier
LA5-H5217	Human	HEK293	Human Laminin 521 Protein, premium grade (Flagship Pro)	Ajouter au panier
LA5-H5246	Human	HEK293	Human Laminin 521 Protein, Research Grade (Flagship)	Ajouter au panier
LA5-H5248	Human	HEK293	Human Laminin 521 Protein, premium grade (Flagship)	Ajouter au panier
RES-A040	Human	-	resDetect™ Human Laminin 521 ELISA Kit (Residue Testing)	Ajouter au panier
SCC-01	Human	-	Laminin 521 Protein Screening Panel	Ajouter au panier

Quantité totale9

Laminin 521Contexte de la molécule

Laminins are a major component of basement membranes. Each laminin molecule is a heterotrimeric glycoprotein composed of one α, one β, and one γ chain. To date, five α, three β, and three γ laminin chains have been identified that associate to form at least 15 laminin isoforms. Laminin 521 is found in the glomerular basement membrane in kidney, in the neuromuscular synaptic cleft in skeletal muscle and in other tissues such as placenta and lung.

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
HNC042	HNC-042	Phase 1 Clinical	Guangzhou Henovcom Bioscience Co Ltd	Influenza A virus infections; Influenza, Human; Influenza B virus infection	Details
Oseltamivir/Pimodivir		Phase 1 Clinical	Johnson & Johnson	Influenza A virus infections	Details
Oseltamivir orally disintegrating tablets	HY-100209	Phase 1 Clinical	Hefei Industrial Pharmaceutical Co Ltd	Influenza A virus infections; Influenza B virus infection	Details

Informations sur les médicaments commercialisés

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Plus ancien nom de marque	Pays d'approbation le plus ancien	Indication la plus ancienne	Société d'approbation la plus ancienne	Date d'approbation la plus ancienne	Indication	Essai clinique
Laninamivir Octanoate Hydrate	CS-8958; R-118958	Approved	Daiichi Sankyo Co Ltd	Inavir	Japan	Influenza B virus infection; Influenza A virus infections; Influenza, Human	null	2010-09-10	Influenza A virus infections; Influenza, Human; Asthma; Influenza B virus infection	Details
Zanamivir	GG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2en	Approved	Glaxosmithkline Plc	依乐韦, Relenza	United States	Influenza, Human	Glaxosmithkline Plc	1999-07-26	Orthomyxoviridae Infections; Diabetes Mellitus, Type 2; Influenza, Human; Arthralgia; Dengue	Details
Oseltamivir Phosphate	Ro-64-0796; GS-4104; RO-640796; GS-4104-002; EN-241104; RO-640796/002; GS-4104/002	Approved	F. Hoffmann-La Roche Ltd	Tamiflu, Hanmi Flu, 达菲	Switzerland	Influenza, Human	F. Hoffmann-La Roche Ltd	1999-09-21	Purpura, Thrombocytopenic, Idiopathic; Influenza A virus infections; Influenza, Human; Influenza in Birds; Obesity; Kidney Failure, Chronic	Details
Peramivir Hydrate	BCX-1812; JNJ-2; S-021812; RWJ-270201	Approved	Biocryst Pharmaceuticals Inc	Peramiflu, Alpivab, 力纬, Rapiacta, Rapivab, Enpiflu Premix	Japan	Influenza, Human	null	2010-01-13	Headache; Cough; Myalgia; Fatigue; Influenza A virus infections; Influenza, Human; Fever; Nasal Obstruction; Pharyngitis; Influenza B virus infection	Details